Better benefits start here

Prime integrates with health plans for total drug management — no matter where medicine happens or how it’s reimbursed. We’re member-centric, provider-aligned and data-driven. And we’re here to help make better, more affordable care easier for everyone.

Blue + Prime

National scale, local control

Prime was created to partner with non-profit Blue health plans, trusted in communities across America. Our integrated model combines national scale with local control to help improve care and lower costs for your clients.

Thought leadership

Driving greater use of biosimilars to help lower drug costs

As part of our total drug management strategy, we actively promote evidence-based use of biosimilars (and other low-cost drug options) and endorsed by our Pharmacy and Therapeutics Committee.

Learn more

Employer groups

Our connected approach helps life be easier for employers. Members get the medicine they need to feel better and live well. Employers can choose products and services that help lower pharmacy benefit costs and improve health outcomes — with less disruption for employees.

Health plans

Created by health plans to be an integrated partner, that unique relationship gives us deeper access to the medical data to help close gaps in care and create an airtight seal on the pharmacy/medical connection. No other pharmacy benefit manager can offer Prime’s level of integration.

Our solutions

We take a deeply integrated, channel independent, holistic approach to designing products that manage cost and provide smarter care that’s right for each person.

Our approach

We are connected where medicines play a role to unlock better, more affordable care.

Our story

Built on the strength from a unique Blue + Prime foundation, we’ve grown from a small pharmacy benefit manager (PBM) to a leading total drug management enterprise.

Related research

Prime analysis

March 17, 2022

Unexpected impacts of COVID-19 go deep in health care, affecting the progress of gene therapy

The impact of COVID-19 on our country has been deep and profound. In…

Drug pipeline updates

March 10, 2022

Gene therapy: A promising future at a high price

Gene therapy modifies a person’s genes to treat or cure disease.1 Unlike most medications,…

Prime analysis

February 24, 2022

Strategy for treating osteoporosis at high risk for fracture using MedDrive™

About 10 million Americans have osteoporosis, a disease of the bone that makes…